ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,437,232 | +645.9% | 212,919 | +757.2% | 0.01% | +500.0% |
| Q2 2023 | $594,894 | +21.6% | 24,839 | -19.1% | 0.00% | -33.3% |
| Q4 2022 | $489,078 | +57.3% | 30,721 | +139.5% | 0.00% | 0.0% |
| Q1 2022 | $311,000 | -87.9% | 12,825 | -73.4% | 0.00% | -91.9% |
| Q4 2020 | $2,578,000 | -67.1% | 48,226 | -70.1% | 0.04% | -67.8% |
| Q2 2020 | $7,825,000 | +2980.7% | 161,431 | +2617.7% | 0.12% | +1337.5% |
| Q4 2019 | $254,000 | – | 5,940 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |